Biosimilar Awareness Initiative Reference Group

The Biosimilar Awareness Initiative Reference Group (the Reference Group) was established to give guidance on the activities of the Biosimilar Awareness Initiative and ensure key messages are clearly articulated and appropriately targeted.

Page last updated: 19 December 2016

The Reference Group consists of representatives from a range of groups, including consumers, healthcare professionals, pharmaceutical industry and healthcare education providers.

The Reference Group had its inaugural meeting in Canberra on 07 April 2016

The second meeting of the Reference Group was held in Canberra on 12 May 2016

The third meeting of the Reference Group was held in Canberra on 18 August 2016

The fourth meeting of the Reference Group was held in Canberra on 29 November 2016

A copy of Dr Paul Cornes’s presentation is available upon request by emailing the National Medicines Policy Section.

In this section